Ticker Symbol: MYGN
Myriad Genetics, Inc.
$29.88 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000899923
Company Profile
Myriad Genetics Inc., is a leading genetic testing and precision medicine company dedicated to transforming patient lives worldwide. Myriad discovers and commercializes genetic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: 320 S Wakara Way
Website: www.myriad.com
CEO: R. Bryan Riggsbee
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $15.45
Change:
-$0.06
(
-0.39%)
Days Range: $15.29 - $15.83
Beta: 1.29
52wk. High: $24.21
52wk. Low: $13.92
Ytd. Change 6.50%
50 Day Moving Average: $16.03
200 Day Moving Average: $19.85
Shares Outstanding: 81883426
Valuation
Market Cap: 126.5B
PE Ratio: -5.05
EPS (TTM): -3.06
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A